IIT Madras’ new AI-based ultrasound scanner to detect sports injury on-field
Chennai, Sep 17 (IANS) Researchers at the Indian Institute of Technology (IIT) Madras have developed an indigenous and portable Point-of-Care-Ultrasound (POCUS) scanner that can diagnose sports injuries on-field. The POCUS, powered by Artificial Intelligence (AI) can potentially allow for on-field diagnosis of injuries, with immediate assessment of the extent of injury that will allow for
Chennai, Sep 17 (IANS) Researchers at the Indian Institute of Technology (IIT) Madras have developed an indigenous and portable Point-of-Care-Ultrasound (POCUS) scanner that can diagnose sports injuries on-field.
The POCUS, powered by Artificial Intelligence (AI) can potentially allow for on-field diagnosis of injuries, with immediate assessment of the extent of injury that will allow for medical professionals to take a call on whether to permit the sportsperson to continue playing.
The novel scanner has a wide range of applications in sports medicine, and it has the benefits of safety (no radiation) and sufficient resolution compared to other modalities, said the team.
“We observed a current technological gap and a need for a point-of-care device for injury management and rehabilitation of elite athletes within routine training premises. A quick assessment for musculoskeletal on the field will help sports players get immediate attention and focus on recovery,” said Prof. Arun K. Thittai, Department of Applied Mechanics and Biomedical Engineering, IIT Madras.
With POCUS, ultrasound technology will be leveraged beyond the hospital setting, in sports medicine.
“We are currently exploring all options to take up POCUS for MSK imaging for commercial translation,” added Thittai, also a faculty member at the varsity’s Center of Excellence in Sports Science and Analytics (CESSA).
Established in 2019 with support from the government’s Institute of Eminence initiative, CESSA aims to become a global platform for fostering innovation in sports technology and delivering products and solutions to enhance athlete performance. The centre will also serve general fitness and health consumers.
Meanwhile, Thittai and the team aim to complete the product prototype development by 2024. They have also planned subsequent testing and collection of pilot data from the field in coordination with Sports Authorities.
–IANS
rvt/
Know all about new XEC Covid variant identified in 15 countries
Next Articleଶ୍ରୀମନ୍ଦିରରେ ଶ୍ରୀଜୀଉଙ୍କ ବଳିବାମନ ବେଶ ଅନୁଷ୍ଠାନ
Related Articles
New AI tool to revolutionise personalised cancer treatment

Health & LifestyleNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

Health & LifestyleCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

Health & LifestyleGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
